Forensic Medicine Laboratory, Department of Oncology-Pathology, Karolinska Institutet, SE 171 76 Stockholm, Sweden; MSD, Gävlegatan 22, SE 113 30 Stockholm, Sweden.
Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, SE 581 85 Linköping, Sweden.
Forensic Sci Int. 2019 Oct;303:109935. doi: 10.1016/j.forsciint.2019.109935. Epub 2019 Aug 28.
BACKGROUND & OBJECTIVES: To improve the interpretation of fatal intoxications by establishing fatal and non-fatal reference concentrations of metformin in postmortem femoral blood and to further evaluate risk factors associated with fatal metformin intoxication.
All forensic autopsies in Sweden where metformin was detected in femoral blood 2011-2016 were identified in the National Board of Forensic Medicine databases (NFMD). The cases were classified as single substance intoxications, A (n = 22), multiple substance intoxications, B (N = 7) and postmortem controls, C (N = 13). The control group consisted of cases where metformin was detected, but the cause of death excluded the incapacitation by metformin or other substances. Strict inclusion criteria were used, and all postmortem cases were assessed by two independent reviewers. All other cases where the inclusion criteria of groups A-C where not met formed group O (N = 78). The forensic findings logged in the NFMD where linked to national registers whereby information on comorbidities, dispensed drugs and clinical data could be obtained.
The mean age was 66 ± 10 years in the total study population and did not differ between the groups. The proportion of men was 64% in group A, 71% in B, 77% in C and 74% in group O. The median values of metformin in group A (48.5 μg/g; range 13.0-210 μg/g) and B (21.0 μg/g; range 4.40-95.0 μg/g) were significantly (p < 0.001 and p = 0.015 respectively) higher than those of the control group C (2.30 μg/g ; range 0.70-21.0 μg/g). The median concentration of metformin in group A and B was also significantly higher than in group O (4.60 μg/g; range 0.64-54.0 μg/g) (p < 0.001 and p = 0.040 respectively). The results suggest that intoxication with metformin as a cause of death should be considered when the postmortem femoral blood level exceeds about 10 μg/g, although higher levels may be seen in postmortem in cases without incapacitation. The metformin intoxication was confirmed to be intentional in 23% (n = 5) of the single intoxications. Underlying factors identified as important for the remaining fatal metformin intoxications included living alone, any contraindication for the use of metformin, known alcohol abuse and a history of stroke or cardiovascular disease.
The reported post mortem femoral blood concentrations of metformin can hopefully contribute to a better interpretation of results in suspected poisonings and obscure cases. Living in a single household, history of cardiovascular disease and contraindications, predominantly alcohol abuse, were associated with fatal metformin intoxication.
通过建立死后股骨血中致命和非致命的二甲双胍参考浓度,提高对致命中毒的解释能力,并进一步评估与致命二甲双胍中毒相关的危险因素。
在 2011 年至 2016 年期间,在全国法医医学数据库(NFMD)中确定了在瑞典所有检测到二甲双胍的法医尸检案例。这些案例被分为单一物质中毒(A 组,n=22)、多种物质中毒(B 组,N=7)和死后对照(C 组,N=13)。对照组由检测到二甲双胍但死因排除了二甲双胍或其他物质引起的丧失能力的案例组成。使用严格的纳入标准,所有死后案例均由两名独立的审查员进行评估。所有不符合 A-C 组纳入标准的其他案例则归入 O 组(N=78)。NFMD 中记录的法医发现与国家登记册相关联,可从中获取合并症、配药药物和临床数据的信息。
在总研究人群中,平均年龄为 66±10 岁,各组之间无差异。男性比例在 A 组为 64%,B 组为 71%,C 组为 77%,O 组为 74%。A 组(48.5μg/g;范围 13.0-210μg/g)和 B 组(21.0μg/g;范围 4.40-95.0μg/g)的二甲双胍中位数显著高于对照组 C 组(2.30μg/g;范围 0.70-21.0μg/g)(p<0.001 和 p=0.015)。A 组和 B 组的二甲双胍中位数浓度也显著高于 O 组(4.60μg/g;范围 0.64-54.0μg/g)(p<0.001 和 p=0.040)。结果表明,当死后股骨血水平超过约 10μg/g 时,应考虑将二甲双胍中毒作为死亡原因,尽管在无丧失能力的情况下,死后可能会出现更高水平的二甲双胍中毒。在 23%(n=5)的单一中毒中,确认二甲双胍中毒为故意中毒。确定与其余致命二甲双胍中毒相关的重要潜在因素包括独居、使用二甲双胍的任何禁忌症、已知的酒精滥用以及中风或心血管疾病的病史。
报告的死后股骨血二甲双胍浓度有望有助于更好地解释疑似中毒和疑难案例的结果。独居、心血管疾病病史和禁忌症、主要为酒精滥用与致命二甲双胍中毒相关。